{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:25:10Z","timestamp":1793413510173,"version":"4.5.0"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T00:00:00Z","timestamp":1652400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"\n Objectives<\/jats:title>\n Ten warning signs of primary immunodeficiency (PID) were suggested by the Jeffrey Modell Foundation (JMF), to increase physician awareness of PID. These warning signs have not yet been evaluated for patients with secondary immunodeficiency (SID). This study investigated whether the 10 warning signs used for the diagnosis of PID were also sufficient for the diagnosis of SID, and explored the possibility of additional signs.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n This prospective study was conducted between June and December 2020. The mothers of 162 patients with PID and SID, and mothers of 200 healthy children, were asked to complete a questionnaire about family and personal history in addition to the warning signs of PID developed by the JMF. A JMF score was created by giving one point for each \u201cYes\u201d answer for the 10 warning signs of PID. Medical records of the patients were evaluated for possible additional warning signs for PID and SID.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n The JMF scores of the PID (3.36 \u00b1 1.65) and SID (3.72 \u00b1 1.12) groups were significantly higher than the scores of the control group (0.34 \u00b1 0.61) (p &lt; 0.05). A sign for immunological evaluation in two patients without warning signs in the PID group was found to be chronic diarrhea. In addition to the 10 JMF warning signs, we found that consanguinity and a family history of tuberculosis were statistically significant in our PID group, compared with the SID and control groups.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n The JMF warning signs are important for early diagnosis of PID. Our study showed that these signs may also be used for the early diagnosis of SID in patients and, according to our results, in addition to the 10 JMF signs for PID, parental consanguinity, chronic diarrhea, and a family history of tuberculosis may also be considered warning signs for the early diagnosis of PID.<\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fimmu.2022.900055","type":"journal-article","created":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T04:38:20Z","timestamp":1652416700000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":43,"title":["Evaluation of the 10 Warning Signs in Primary and Secondary Immunodeficient Patients"],"prefix":"10.3389","volume":"13","author":[{"given":"Fadime Ceyda","family":"Eldeniz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahya","family":"Gul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaaddin","family":"Yorulmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukru Nail","family":"Guner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevgi","family":"Keles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail","family":"Reisli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s10875-019-00737-x","article-title":"Human Inborn Errors of Immunity: 2019 Update on the Classification From the International Union of Immunological Societies Expert Committee","volume":"40","author":"Tangye","year":"2020","journal-title":"J Clin Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10875-012-9751-7","article-title":"Primary Immunodeficiency Diseases Worldwide: More Common Than Generally Thought","volume":"33","author":"Bousfiha","year":"2013","journal-title":"J Clin Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-018-8996-5","article-title":"Global Report on Primary Immunodeficiencies: Update From the Jeffrey Modell Centers Network on Disease Classification, Regional Trends, Treatment Modalities, and Physician Reported Outcomes","volume":"66","author":"Modell","year":"2018","journal-title":"Immunol Res"},{"key":"B4","article-title":"Retrospective Evaluation of 1054 Patients With Primary Immunodeficiency","volume":"6","author":"Yorulmaz","year":"2008","journal-title":"Asthma Allergy Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s10875-012-9763-3","article-title":"The Prevalances and Patient Characteristics of Primary Immunodeficiency Diseases in Turkey-Two Centers Study","volume":"33","author":"Kilic","year":"2013","journal-title":"J Clin Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2010-3680","article-title":"Clinical Features That Identify Children With Primary Immunodeficiency Diseases","volume":"127","author":"Subbarayan","year":"2011","journal-title":"Pediatrics"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.2174\/1871530319666190828125316","article-title":"Diagnostic Approach to the Patients With Suspected Primary Immunodeficiency","volume":"20","author":"Tavakol","year":"2020","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"B8","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s10875-020-00758-x","article-title":"Human Inborn Errors of Immunity: 2019 Update of the IUIS Phenotypical Classification","volume":"40","author":"Bousfiha","year":"2020","journal-title":"J Clin Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-017-8907-1","article-title":"Modeling Strategy to Identify Patients With Primary Immunodeficiency Utilizing Risk Management and Outcome Measurement","volume":"65","author":"Modell","year":"2017","journal-title":"Immunol Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/ACI.0b013e3283591534","article-title":"The 10 Warning Signs: Time for a Change","volume":"12","author":"O'Sullivan","year":"2012","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"88","DOI":"10.4168\/aair.2013.5.2.88","article-title":"Clinical Predictors of Primary Immunodeficiency Diseases in Children","volume":"5","author":"Reda","year":"2013","journal-title":"Allergy Asthma Immunol Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/S0031-3955(05)70268-6","article-title":"Office Evaluation of Children With Recurrent Infection","volume":"47","author":"Woroniecka","year":"2000","journal-title":"Pediatr Clinics North America"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-007-8041-2","article-title":"Approach to the Patient With Recurrent Infections","volume":"34","author":"Ballow","year":"2008","journal-title":"Clin Rev Allergy Immunol"},{"key":"B14","article-title":"Alteration in Humoral Immunity Is Common Among Family Members of Patients With Common Variable Immunodeficiency","volume":"24","author":"Karakoc-Aydiner","year":"2014","journal-title":"J Investig Allergol Clin Immunol"},{"key":"B15","article-title":"X-Linked Immunodeficiency","volume-title":"StatPearls","author":"Aytekin","year":"2021"},{"key":"B16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s12026-011-8241-y","article-title":"Global Study of Primary Immunodeficiency Diseases (PI)\u2013Diagnosis, Treatment, and Economic Impact: An Updated Report From the Jeffrey Modell Foundation","volume":"51","author":"Modell","year":"2011","journal-title":"Immunol Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.aller.2013.02.004","article-title":"Investigation of Underlying Primary Immunodeficiencies in Patients With Severe Atopic Dermatitis","volume":"42","author":"Aghamohammadi","year":"2014","journal-title":"Allergol Immunopathol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1749-6632.2011.06206.x","article-title":"Ten Warning Signs of Primary Immunodeficiency: A New Paradigm Is Needed for the 21st Century","volume":"1238","author":"Arkwright","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.aller.2020.03.005","article-title":"Evaluation of the Frequency and Diagnostic Delay of Primary Immunodeficiency Disorders Among Suspected Patients Based on the 10 Warning Sign Criteria: A Cross-Sectional Study in Iran","volume":"48","author":"Bahrami","year":"2020","journal-title":"Allergol Immunopathol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.900055\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T04:38:24Z","timestamp":1652416704000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.900055\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,13]]},"references-count":19,"alternative-id":["10.3389\/fimmu.2022.900055"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.900055","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,13]]},"article-number":"900055"}}